The Pascal laser is a new, innovative tool
designed to treat
retina
conditions like
diabetic retinopathy and
retinal holes and tears. It is unique to any
previous laser instrument in that it delivers a
“single-shot”, predetermined pattern of multiple,
precision laser applications. This allows for much
quicker, safer application and much less discomfort
to the patient.
Thirty minute laser
treatments, delivering hundreds of shots to the
retina are now a thing of the past at
The Macula Center. Large
treatments of hundreds of precisely positioned laser
applications can be completed in five minutes or
less using the Pascal laser.
Dr. Deupree
added the Pascal laser to his modern, high-tech
arsenal of patient diagnostic and treatment tools in
order to better serve his diabetic patients.
Diabetic retinopathy represents a large percentage
of the many vitreo-retinal diseases he manages in
his practice.
In 2005, the FDA approved the
Pascal laser for use on vascular and structural
conditions of the retina. The Pascal is most
commonly used for:
The information provided on this
website is for informational purposes only and is not intended to
substitute, supplant or augment any advice from your physician or other health care
professional or medication label. You should not use the information on this site for
diagnosis or treatment of any eye or health problem or for prescription of
any medication or other treatment. You should consult with a
healthcare professional before starting any diet, exercise or
supplementation program, before taking any medication, or if you
have or suspect you might have a health problem. You should not stop
taking any medication or change your course of treatment without first consulting your physician.
The Macula Center does not endorse, guarantee or make any claims for
or about any products or information linked to from this website.
Dr. Deupree
added the Pascal laser to his modern, high-tech
arsenal of patient diagnostic and treatment tools in
order to better serve his diabetic patients.
Diabetic retinopathy represents a large percentage
of the many vitreo-retinal diseases he manages in
his practice.
